Celldex Therapeutics (CLDX) Q4 2024 Earnings

6NovConfirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-0.83
-0.73
-0.64
-0.54

Details

Expected EPS
-0.672547
Actual EPS
-0.64
Surprise EPS
0.03
Surprise Percent
+4.84%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.64 per share for Q4 2024.

0 Comments

Share your thoughts